Loading patent…
AssigneeThe Picower Institute for Medical Research
InventorsYong Ming Li, Helen Vlassara, Anthony Cerami
Estimating the term…
The present invention is directed to compositions and devices based upon the unexpected discovery that certain antibacterial proteins, in particular lysozyme and lactoferrin, bind to advanced glycosylation endproducts (AGEs) with high affinity, and that this binding activity is substantially noncompetitive with binding of bacterial carbohydrates to the antibacterial proteins. Accordingly, the invention relates to methods for treating diseases and disorders associated with increased levels of AGEs, by using compositions and devices having associated therewith a molecule having a hydrophilic loop domain, which domain is associated with AGE-binding activity, and compositions comprising such a domain. The invention further relates to compositions and devices for partitioning AGEs away from a sample.
A composition for use in hemodialysis for partitioning advanced glycosylation endproducts (AGEs) out of a biological sample comprising an amount of a molecule effective to bind AGEs in a biological sample, said molecule being irreversibly associated with a dialysis membrane, said molecule exclusive of lysozyme and lactoferrin and having at least one structure corresponding to R.sub.1 Cys.sub.1 Xaa.sub.n Cys.sub.2 R.sub.2 (SEQ ID NOS:1-9), wherein Cys.sub.1 and Cys.sub.2 may be cross-linked and Cys.sub.1 and Cys.sub.2 together with Xaa.sub.n is an AGE-binding, hydrophilic peptide sequence:
A device for use in hemodialysis for partitioning advanced glycosylation endproducts (AGEs) out of a biological sample comprising a structure fabricated of an AGE-permeable material, which structure contains particles to which an amount of a molecule effective to bind AGEs in a biological sample is irreversibly associated or immobilized, said molecule exclusive of lysozyme and lactoferrin and having at least one structure corresponding to R.sub.1 Cys.sub.1 Xaa.sub.n Cys.sub.2 R.sub.2 (SEQ ID NOS:1-9), wherein Cys.sub.1 and Cys.sub.2 may be cross-linked and Cys.sub.1 and Cys.sub.2 together with Xaa.sub.n is an AGE-binding, hydrophilic peptide sequence;
Dependencies are inferred from the claim text.